Dynamic Regulation and Therapeutic Translation of Histone Modifications in Colorectal Cancer
JIA Mengxuan1, LIU Gang2*
CRC (colorectal cancer) is one of the common malignant tumors of the digestive tract in China. Its incidence and mortality rates remain relatively high, and existing treatments have certain limitations in improving progno sis for advanced patients. The occurrence and development of CRC are closely related to genetic mutations and are also influenced by chromatin status, metabolic stress, inflammatory signals, and treatment selection pressure. HPTMs (histone post-translational modifications), as an important component of epigenetic regulation, possess reversibility, site specificity, and metabolic microenvironment dependency. They remodel chromatin structure and regulate gene transcription programs through methylation, acetylation, and novel acylation modifications, thereby participating in the development and evolu tion of CRC. This paper systematically reviews the dynamic regulatory network mechanisms and epigenetic vulnerabilities of histone modifications in CRC, focusing on the imbalance in the Writer-Eraser-Reader regulatory network, the crosstalk mechanisms between histone modifications and other epigenetic levels, and further evaluates the potential application value of HDAC inhibitors, KDM/KMT inhibitors, and novel epigenetic drugs targeting lactylated modifications in inhibiting CRC progression, enhancing chemotherapy sensitivity, and combining immunotherapy. This study provides new ideas for optimizing molecular typing, efficacy prediction, and epigenetic targeted therapy strategies for CRC.



CN
EN